842-P: Improvement in Time in Range after Smart Insulin Pen Initiation in Austria

Introduction & Objectives: A prior multinational study showed improved time in range (TIR; 70-180 mg/dL) in people living with type 1 or type 2 diabetes (PLWD) after smart pen initiation for their bolus insulin. To understand country-specific experiences with smart pen use, this study replicated the analysis, focusing on PLWD in Austria. Methods: Real-world data (RWD) were collected from adults in Austria on a multiple daily insulin regimen who were already using a continuous glucose monitoring (CGM) device and initiating a smart pen. Days were included if an individual had ≥1 data upload (pen to app) within the last 14 days and ≥15% time covered by CGM sensor readings. Key glycemic outcomes were TIR and time below range (TBR; 70% increased from 35% at baseline to 42% at 6 months (p < 0.001). Conclusion: RWD from Austria shows a clear glycemic improvement after smart pen initiation. Analyzing country-specific experiences is important to understand the potential impact of smart pen use and how PLWD and physicians can most benefit from this technology.